This kinase phosphorylation is usually observed in conditioning treatments, with a peak of the pERK/total ERK ratio 10–15 min after the end of ischemia and a progressive reduction thereafter (Ferdinandy et al., 2014; Penna et al., 2014; Cohen and Downey, 2015). The gene discussed is MAPK1; the disease is ischemia.